Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, September 1 2014 8:01am ET - U.S. Markets open in 1 hour and 29 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Monday, Sep 1, 2014
·EU regulators set Oct. 3 deadline for Eli Lilly, Novartis deal
Reuters - 1 hour, 11 minutes ago
·Novartis Rises Most in Five Months on Heart-Drug Trial
at Bloomberg - Mon 3:27 am ET
·Astra heart pill safe to use in ambulance but no extra benefit
Reuters - Mon 3:00 am ET
Sunday, Aug 31, 2014
·Cholesterol Drug Halves Heart Attack and Stroke in Early Test
at The New York Times - Sun 6:36 pm ET
·SIGNIFY Trial Provokes Sound And Fury Over Controversial Servier and Amgen Drug
at - Sun 11:33 am ET
·Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
PR Newswire - Sun 3:00 am ET
·Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
PR Newswire - Sun 3:00 am ET
Saturday, Aug 30, 2014
·The Most Interesting Man Revolutionizing The Health World
at - Sat 8:31 am ET
·Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
PR Newswire - Sat Aug 30
·New Novartis Drug Effective in Treating Heart Failure
at The New York Times - Sat Aug 30
·Novartis Heart Failure Drug Tops Standard in Study
at Bloomberg - Sat Aug 30
·PARADIGM-HF Establishes a New Paradigm for Heart Failure Treatment
at - Sat Aug 30
·Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE)
Business Wire - Sat Aug 30
·UPDATE 1-Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk
Reuters - Sat Aug 30
Friday, Aug 29, 2014
·EQUITY ALERT: Rosen Law Firm Reminds Impax Laboratories' Investors of Important Class Action Deadline -- IPXL
GlobeNewswire - Fri Aug 29
·Final Glance: Pharmaceuticals companies
AP - Fri Aug 29
·SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Impax Laboratories, Inc. of Class Action Lawsuit and Upcoming Deadline -- IPXL
GlobeNewswire - Fri Aug 29
·United Therapeutics Legal Victory Sends Stock Flying
at Investor's Business Daily, Inc. - Fri Aug 29
·Partnering With Big Pharma, Parexel Hits Its Stride
at Investor's Business Daily, Inc. - Fri Aug 29
·Investors Bet AstraZeneca Megamerger Could Live Again
at Bloomberg - Fri Aug 29
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
Accelerated Study Start
Clinical trial site identification, feasibility, and activation.
M/A/R/C Research
Custom Research
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?